Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Finasteride helps induce ovulation in nonresponder PCOS women.

Finasteride doesn't affect ovulation in normal women.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Hirsutism significantly lowers the quality of life for Turkish women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

PSA can help diagnose high androgen levels in women.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.